Upcoming Workshops
For Breast Cancer
For Mantle Cell Lymphoma
For Ovarian Cancer
For Prostate Cancer
For Thyroid Cancer
For Uterine Cancer
Past workshops
For All Cancers
- Understanding Diagnostic Technologies and Biomarkers
- Clinical Trials: How They Transform the Treatment of Cancer
- Understanding Diagnostic Technologies and Biomarkers
- Chemotherapy Treatment Side Effects: Prevention & Management
- Clinical Trials: How They Transform the Treatment of Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Clinical Trials: How They Transform the Treatment of Cancer
- What’s New in Precision Medicine
- What’s New in Diagnostic Technologies for People Living with Solid Cancer TumorsPart I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer
- Understanding Diagnostic Technologies and Biomarkers
- Trends in Oncology and Treatment Planning: What You Need to KnowPart I of Life with Cancer: A Guide to Getting the Best Care
For Acute Lymphoblastic Leukemia
For Acute Myeloid Leukemia
For Bladder Cancer
For Bone Cancer
For Breast Cancer
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Breast Cancer: Treatment Updates
For Chronic Lymphocytic Leukemia
For Chronic Myelogenous Leukemia
For Colorectal Cancer
For Cutaneous T-Cell Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Diffuse Large B-Cell Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Endometrial Cancer
For Follicular Lymphoma
For Gastric Cancer
For Gastrointestinal Stromal Tumors
For Head and Neck Cancer
For Hodgkin Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Leukemia
For Liver Cancer
For Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Small Cell Lung Cancer: Biomarker Testing & Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
- What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
- Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
- Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: Genomic Testing & Current Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
For Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Mantle Cell Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Marginal Zone Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Melanoma
For Mesothelioma
For Metastatic Breast Cancer
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Breast Cancer: Treatment Updates
For Multiple Myeloma
For Non-Hodgkin Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Ovarian Cancer
For Peripheral T-Cell Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Prostate Cancer
For Skin Cancer
For Small Lymphocytic Lymphoma
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Stomach Cancer
For Triple Negative Breast Cancer
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer: Treatment Updates